JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fontrier, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fontrier, T.

Anesth Analg 2004;98:1505
© 2004 International Anesthesia Research Society
doi: 10.1213/01.ANE.0000114584.16029.0D

LETTERS TO THE EDITOR

Lithium for Fibromyalgia

Toinette Fontrier, MD

Department of Anesthesiology, Wake Forest University Medical Center, Winston-Salem, NC

To the Editor:

I feel ethically obligated to write this letter. I am an anesthesiologist and have been disabled by fibromyalgia for over 10 years. During this time, my husband, John Lewis, also an anesthesiologist, and I have been studying the disease.

After excess activity, a major component of my pain can become debilitating, affecting all aspects of life and preventing sleep. This pain is not responsive to opioids, NSAIDs, or gabapentin. However, a dose of 300 mg of lithium carbonate will decrease the pain by 70–80% within 40 minutes. The effect lasts 4–5 hours. It is dramatic. It is reproducible. There is precedent for its use (1,2).

Dr. Lewis and I believe that fibromyalgia may be related to a calcium-parathyroid axis dysfunction. Lithium causes a brief rise in parathyroid hormone. Perhaps this is the reason for the drug’s efficacy (3).

Lithium has a long history of safe use. It is inexpensive and readily available. Side effects are usually well tolerated. If large doses are needed, blood levels should be monitored. It is worth a try.

References

  1. Tyber MA. Lithium carbonate augmentation therapy in fibromyalgia. Can Med Assoc J 1990; 143: 902–4.[Medline]
  2. Teasell RW. Lithium therapy for fibromyalgia [letter]. Can Med Assoc J 1991; 144: 122–3.
  3. Lewis JM, Fontrier T. Lithium and fibromyalgia. J Musculoskeletal Pain 2003; 11: 69–70.




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fontrier, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fontrier, T.

Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press